Financial Consulate’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Financial Consulate's REGN Position: Q2 2026 in Review
Financial Consulate reduced its Regeneron Pharmaceuticals (REGN) stake by 35% in Q2 2026, selling an estimated $4.76K and leaving 13 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #732.
Financial Consulate first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $15.5K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Financial Consulate held 13 shares of Regeneron Pharmaceuticals worth $8.11K as of Q2 2026.
- Financial Consulate sold 7 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.76K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #732 holding.
- Financial Consulate first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- Financial Consulate's Regeneron Pharmaceuticals position peaked at $15.5K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.